Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Pacira BioSciences, Inc.’s reported figures.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
FAQ
- What is Pacira BioSciences, Inc.'s EBIT?
- Pacira BioSciences, Inc. (PCRX) reported EBIT of $6.9M in Q1 2026.
- How has Pacira BioSciences, Inc.'s EBIT changed year-over-year?
- Pacira BioSciences, Inc.'s EBIT increased by 246.8% year-over-year, from $1.99M to $6.9M.
- What is the long-term trend for Pacira BioSciences, Inc.'s EBIT?
- Over 2 years (2021 to 2025), Pacira BioSciences, Inc.'s EBIT has grown at a -53.8% compound annual growth rate (CAGR), from $89.92M to $19.19M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Pacira BioSciences, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude